×
About 11,890 results

ALLMedicine™ Parkinson Disease Center

Research & Reviews  4,114 results

Comparison of 18F-DOPA and 18F-DTBZ for PET/CT Imaging of Idiopathic Parkinson Disease.
https://doi.org/10.1097/RLU.0000000000004361
Clinical Nuclear Medicine; Shi X, Yang Y et. al.

Aug 13th, 2022 - The aim of this study was to compare 2 imaging tracers, 18F-DOPA and 18F-DTBZ, for PET/CT imaging in idiopathic Parkinson disease (PD). We recruited 32 PD patients and 12 healthy controls in this study. All subjects underwent both 18F-DOPA and 18F...

Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carb...
https://doi.org/10.1097/MD.0000000000029526
Medicine Valkovič P, Minár M et. al.

Aug 13th, 2022 - Patients with Parkinson disease (PD) treated with levodopa/carbidopa intestinal gel (LCIG) have higher prevalence of hyperhomocysteinemia and peripheral nerves damage. The aim of our study was to test the effect of catechol-O-methyl transferase in...

Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease
https://clinicaltrials.gov/ct2/show/NCT05348837

Aug 12th, 2022 - The cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and rigidity. Though non-motor features have been recognized for centuries, only recently has the prevalence and impact of non-motor symptoms become the foc...

Characterizing Lewy Pathology in 231 Essential Tremor Brains From the Essential Tremor ...
https://doi.org/10.1093/jnen/nlac068
Journal of Neuropathology and Experimental Neurology; Louis ED, Iglesias-Hernandez D et. al.

Aug 12th, 2022 - The Essential Tremor Centralized Brain Repository is the largest repository of prospectively collected essential tremor (ET) brains (n = 231). Hence, we are uniquely poised to address several questions: What proportion of ET cases has Lewy patholo...

Imaging Biomarkers in Parkinson s Disease
https://clinicaltrials.gov/ct2/show/NCT01496599

Aug 12th, 2022 - Objectives: The purpose of this protocol is to evaluate possible imaging biomarkers for diagnosis and assessment of disease progression in Parkinson disease (PD) through multi-modal neuroimaging studies. The study will have two parts: Part 1: Comp...

see more →

Guidelines  1 results

Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046970
Physical Therapy; Osborne JA, Botkin R et. al.

Dec 29th, 2021 - A clinical practice guideline on Parkinson disease was developed by an American Physical Therapy Association volunteer guideline development group that consisted of physical therapists and a neurologist. The guideline was based on systematic revie...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  395 results

Imaging Biomarkers in Parkinson s Disease
https://clinicaltrials.gov/ct2/show/NCT01496599

Aug 12th, 2022 - Objectives: The purpose of this protocol is to evaluate possible imaging biomarkers for diagnosis and assessment of disease progression in Parkinson disease (PD) through multi-modal neuroimaging studies. The study will have two parts: Part 1: Comp...

Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease
https://clinicaltrials.gov/ct2/show/NCT05348837

Aug 12th, 2022 - The cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and rigidity. Though non-motor features have been recognized for centuries, only recently has the prevalence and impact of non-motor symptoms become the foc...

Istradefylline for Parkinson Disease With Cognitive Impairment
https://clinicaltrials.gov/ct2/show/NCT05333549

Aug 11th, 2022 - Istradefylline has been approved by the U. S. Food and Drug Administration (FDA) to reduce "off" episodes in Parkinson disease. The period when levodopa has a positive effect on Parkinson's symptoms is called on-time. Once the medication stops wor...

Reference Values for Videofluoroscopic Measures of Swallowing
https://clinicaltrials.gov/ct2/show/NCT05497219

Aug 11th, 2022 - Dysphagia (swallowing impairment) is a serious health condition seen in many age-related disease and injury processes. Although videofluoroscopy (VF) is an international "gold standard" dysphagia diagnostic exam, there is a paucity of available no...

Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
https://clinicaltrials.gov/ct2/show/NCT00302146

Aug 9th, 2022 - An association between Gaucher disease and parkinsonism has been demonstrated by the concurrence of parkinsonian manifestations in patients with Gaucher disease and an increased incidence of glucocerebrosidase (GBA) mutations in subjects with park...

see more →

News  236 results

Don’t overlook this cause of falls
https://www.mdedge.com/familymedicine/article/255459/geriatrics
MDedge Family Medicine; Ernestine Lee, MD, MPH

Jun 15th, 2022 - I enjoyed reading “How to identify balance disorders and reduce fall risk” (J Fam Pract. 2022;71:20-30) from the January/February issue.

Lithium Linked to Dementia Prevention
https://www.medpagetoday.com/psychiatry/dementia/97725

Mar 17th, 2022 - Treatment with lithium may be protective against dementia and its subtypes, a retrospective cohort study indicated. Among patients receiving mental health care, those exposed to lithium at standard clinical dosages had a 44% lower risk of receivin...

DMARDs or corticosteroids use may not explain reduced risk for Parkinson disease in RA
https://www.mdedge.com/rheumatology/article/252183/rheumatoid-arthritis/dmards-or-corticosteroids-use-may-not-explain

Feb 24th, 2022 - Key clinical point: The use of disease-modifying antirheumatic drugs (DMARD) or corticosteroids did not affect the risk for Parkinson's disease (PD) in patients with rheumatoid arthritis (RA), except for chloroquine/hydroxychloroquine, which may b.

Neurology Case Challenge: Visual and Auditory Hallucinations in a Patient With Parkinson Disease
https://www.medscape.com/viewarticle/736108

Jan 21st, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Survey identifies clinicians’ unease with genetic testing
https://www.mdedge.com/neurology/article/246396/parkinsons-disease/survey-identifies-clinicians-unease-genetic-testing
Richard Mark Kirkner

Sep 21st, 2021 - Before getting to work on developing guidelines for genetic testing in Parkinson’s disease, a task force of the Movement Disorders Society surveyed members worldwide to identify concerns they have about using genetic testing in practice. In result.

see more →

Patient Education  3 results see all →